| Pharmaceutical active ingredients: |
| Hydroxyurea |
| Available forms, composition and doses of Cytodrox: |
| Capsules; Oral; Hydroxyurea 500 mg |
| Cytodrox medical category: |
| Human:Antineoplastic agentsCytotoxic chemotherapy |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| L01XX05 - Hydroxycarbamide |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Cipla |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Cytocom-E | Efavirenz; Lamivudine; Zidovudine | Alkem Laboratories |
| Cytocom-N | Lamivudine; Nevirapine; Zidovudine | Alkem Laboratories |
| Cytocristin | Vincristine Sulfate | Cipla |
| Cytodec | Diclofenac Potassium; Serrapeptase | Ankom Laboratories |
| Cytodec Forte | Acetaminophen; Diclofenac Potassium; Serrapeptase | Ankom Laboratories |
| CytoFab | Anti-TNF-Alpha Polyclonal Antibody | AstraZeneca |
| Cytoflavin | Inosine; Succinic Acid; Vitamin B2 (Riboflavin Mononucleotide); Vitamin B3 (Nicotinamide) | Polysan |
| Cytofol | Folic Acid | Unidentified Pharmaceutical Company |
| Cytofos | Amifostine | Sun Pharmaceutical Industries |
| CytoGam | Cytomegalovirus Immune Globulin Human | Medimmune; CSL; Purissimus |